Upgrade to SI Premium - Free Trial

Stoke Therapeutics Inc. (STOK)

28.96 +0.15 (0.52%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/10/26)

Latest Headlines

Form 4 Stoke Therapeutics, Inc. For: Jul 16 Filed by: Harrison Seth Loring July 17, 2026 4:37 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jul 15 Filed by: McCauley Thomas July 17, 2026 4:36 PM - SEC Filing Form 3 Stoke Therapeutics, Inc. For: Jul 13 Filed by: McCauley Thomas July 17, 2026 4:33 PM - SEC Filing Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) July 16, 2026 4:01 PM - BizWire Stoke Therapeutics names Thomas McCauley as chief scientific officer July 13, 2026 7:30 AM - StreetInsider Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer July 13, 2026 7:30 AM - BizWire Goldman Sachs Starts Stoke Therapeutics (STOK) at Buy July 13, 2026 5:10 AM - StreetInsider Form 4 Stoke Therapeutics, Inc. For: Jul 01 Filed by: Ticho Barry July 6, 2026 4:11 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: Ticho Barry July 1, 2026 4:52 PM - SEC Filing Form 8-K Stoke Therapeutics, Inc. For: Jun 30 June 30, 2026 8:02 AM - SEC Filing Stoke Therapeutics completes enrollment in Phase 3 Dravet study June 30, 2026 8:01 AM - StreetInsider Stoke Therapeutics Announces Completion of Enrollment of 162 Patients Into the Phase 3 EMPEROR Study of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome June 30, 2026 8:00 AM - BizWire Form 4 Stoke Therapeutics, Inc. For: Jun 16 Filed by: Allan Jonathan June 18, 2026 4:19 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: Allan Jonathan June 16, 2026 4:34 PM - SEC Filing Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) June 16, 2026 4:01 PM - BizWire Form 4 Stoke Therapeutics, Inc. For: Jun 03 Filed by: TZIANABOS ARTHUR June 5, 2026 4:33 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jun 03 Filed by: Smith Julie June 5, 2026 4:32 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jun 03 Filed by: LEVIN ARTHUR A June 5, 2026 4:31 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jun 03 Filed by: Krainer Adrian R. June 5, 2026 4:29 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jun 03 Filed by: Kaye Edward M. MD June 5, 2026 4:28 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jun 03 Filed by: Harrison Seth Loring June 5, 2026 4:26 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jun 03 Filed by: Burstein Jennifer June 5, 2026 4:24 PM - SEC Filing Form 8-K Stoke Therapeutics, Inc. For: Jun 03 June 4, 2026 4:08 PM - SEC Filing Form 4 Stoke Therapeutics, Inc. For: Jun 01 Filed by: Ticho Barry June 3, 2026 5:34 PM - SEC Filing Stoke Therapeutics to Present at Upcoming Investor Conferences in June May 28, 2026 4:01 PM - BizWire Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: Lynx1 Capital Management LP May 18, 2026 9:30 PM - SEC Filing Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) May 18, 2026 4:01 PM - BizWire Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: Lynx1 Capital Management LP May 15, 2026 4:36 PM - SEC Filing Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: Redmile Group, LLC May 15, 2026 4:25 PM - SEC Filing Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: TORONTO DOMINION BANK May 15, 2026 1:47 PM - SEC Filing Form SCHEDULE 13G/A Stoke Therapeutics, Inc. Filed by: RTW INVESTMENTS, LP May 15, 2026 8:32 AM - SEC Filing Form SCHEDULE 13G Stoke Therapeutics, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP May 15, 2026 7:06 AM - SEC Filing Form 8-K Stoke Therapeutics, Inc. For: May 07 May 7, 2026 4:23 PM - SEC Filing Stoke Therapeutics, Inc. (STOK) Tops Q1 EPS by 2c May 7, 2026 4:15 PM - StreetInsider Form 10-Q Stoke Therapeutics, Inc. For: Mar 31 May 7, 2026 4:08 PM - SEC Filing Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates May 7, 2026 4:01 PM - BizWire Form 4 Stoke Therapeutics, Inc. For: May 01 Filed by: Ticho Barry May 5, 2026 4:19 PM - SEC Filing Form 144 Stoke Therapeutics, Inc. Filed by: Ticho Barry May 1, 2026 4:44 PM - SEC Filing Stoke Therapeutics to Host Webcast and Conference Call to Discuss First Quarter 2026 Business and Financial Updates April 30, 2026 4:01 PM - BizWire Full Article List